BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• 

  Business

  Accent Therapeutics Launches with $40 Million: Focus on RNA-Modifying Proteins

  Accent Therapeutics, headquartered in Cambridge, Massachusetts, closed on a $40 million Series A financing. Accent will focus on the fairly new area of epitranscriptomics.

  May 18, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  FDA Approves Amgen and Novartis Migraine Drug Aimovig, Expected to Be Ready for Patients in 1 Week

  Amgen and Novartis scored a big win in the migraine market late Thursday when the U.S. Food and Drug Administration approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults.

  May 18, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  Retailers File Lawsuit Against Allergan over Restasis Patents

  Allergan has gone to great lengths to defend the patents for its blockbuster dry-eye drug Restasis and it looks like the company will have to head back to court again.

  May 18, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Novo Nordisk and UC San Francisco Pushing Toward a Diabetes Cure

  Danish company Novo Nordisk is a leader in diabetes treatment, but this week announced it was upping its commitment to stem-cell-based therapies and expanding its focus.

  May 18, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Another One Bites the Dust: J&J Kills Early Alzheimer’s Program

  Johnson & Johnson’s Janssen division has decided to end its trials of atabacestat, a BACE inhibitor, for Alzheimer’s disease.

  May 18, 2018

   · 

  2 min read

   · 

  Mark Terry
• Business

  Pennsylvania Hospitals Acquire Advanced Cancer Management Systems From Elekta

  Allegheny Health Network’s investment to expand radiation oncology services at four network facilities includes Elekta’s cutting-edge products and services

  May 18, 2018

   · 

  5 min read
• Drug Development

  Additional Remetinostat Phase II Data Will be Presented at the International Investigative Dermatology Meeting on May 18 and 19

  The focus of the presentation is the effect of remetinostat on reducing pruritis (itching), as seen in the phase II study.

  May 18, 2018

   · 

  3 min read
• Pivot Accelerates Development of CBD Products for Domestic Pet Market

  Based on RTIC Ready-To-Infuse-Cannabis Powder and Thrudermic Transdermal Cream

  May 18, 2018

   · 

  4 min read
• Business

  Accent Therapeutics Announces Company Launch with $40 Million Series A Financing for Novel, Precision Cancer Treatments Targeting RNA-Modifying Proteins

  Company establishes platform strategy to lead development of promising new precision therapies in the emerging field of epitranscriptomics

  May 18, 2018

   · 

  4 min read
• Biotech Bay

  NeoTract Announces American Urological Association (AUA) Recommendation of UroLift® System as a Standard of Care Option for the Treatment of Enlarged Prostate

  UroLift® System recommended as a standard of care treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH).

  May 18, 2018

   · 

  5 min read